Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Enterprise value to EBITDA ratio
Percentile
P75
Within normal range
vs 2Y Ago
-0.2x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -3.66 | +42.6% |
| 2024 | -6.38 | -126.5% |
| 2023 | 24.05 | +246.2% |
| 2022 | -16.46 | -20.4% |
| 2021 | -13.67 | - |